News

August 13, 2020
|
Category:

Dewpoint featured in Business Insiders list of biotech start-ups set to take off

We are proud to have been featured by Business Insider as one of 21 start-ups considered by top biotech venture capital investors to be poised to take off in the next 12 months. 

Read more on businessinsider.com

Media Contact

media@dewpointx.com

Investor Contact

Michael Fenn, PH.D.
Head of External Innovation
Dewpoint Therapeutics
mfenn@dewpointx.com
Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science